Matinas Biopharma Holdings, Inc. Common Stock — Cash Flow (NYSE:MTNB)

Financials

Cash from operating activities -17.37 M-15.22 M-19.16 M-15.28 M-15.88 M-7.01 M -6.42 M Cash from investing activities -40.67 M16.77 M4.88 M13.24 M9.21 M335 K — Cash from financing activities 48.05 M6.96 M79 K-7 0009.17 M3.39 M — Free cash flow -17.37 M-15.22 M-19.16 M-15.28 M-15.88 M-7.01 M -6.42 M

News

MTNB

Financials

News

Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO

Matinas BioPharma amends CEO employment agreement to revise retention bonus terms

Matinas BioPharma CFO Keith Kucinski to step down in January

Oragenics appoints Natasha Giordano to board of directors

Matinas BioPharma exchanges warrants for 466,666 shares of common stock